Cite
MLA Citation
Sanjeev Forsyth et al.. “Safety, Pharmacokinetics, and Pharmacodynamics of Etavopivat (FT‐4202), an Allosteric Activator of Pyruvate Kinase‐R, in Healthy Adults: A Randomized, Placebo‐Controlled, Double‐Blind, First‐in‐Human Phase 1 Trial.” Clinical pharmacology in drug development, vol. 11, no. 5, 2022, pp. 654–665. http://access.bl.uk/ark:/81055/vdc_100154237929.0x000008